These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 533015)

  • 1. Serial hemodynamic studies during the treatment of congestive heart failure with isolated low-dose oral prazosin therapy.
    Reyns PR; Romney D; Desser KB; Benchimol A
    Angiology; 1979 Dec; 30(12):850-5. PubMed ID: 533015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vasodilator therapy with prazosin for severe congestive heart failure--hemodynamic effects of oral single administration and chronic use (author's transl)].
    Akamatsu T; Suzuki A; Yamamoto T; Takahashi S; Kimata S; Hirosawa K
    Kokyu To Junkan; 1979 Sep; 27(9):991-7. PubMed ID: 538350
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effects of prazosin in patients with chronic refractory heart failure-acute hemodynamic effects of oral prazosin and long-term therapy (author's transl)].
    Honda T; Hiramori K; Haze K; Saito M; Fuseno H; Fukami K; Umemoto M; Tanaka N; Ikeda M
    Kokyu To Junkan; 1981 May; 29(5):527-35. PubMed ID: 7313357
    [No Abstract]   [Full Text] [Related]  

  • 4. Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure.
    Elkayam U; Lejemtel TH; Mathur M; Ribner HS; Frishman WH; Strom J; Sonnenblick EH
    Am J Cardiol; 1979 Sep; 44(3):540-5. PubMed ID: 474434
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
    Desch CE; Magorien RD; Triffon DW; Blanford MF; Unverferth DV; Leier CV
    Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of captropril in chronic heart failure: efficacy of low-dose treatment and comparison with prazosin.
    Sharpe DN; Coxon R
    Am Heart J; 1982 Nov; 104(5 Pt 2):1164-71. PubMed ID: 6291361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prazosin and congestive heart failure: short- and long-term therapy.
    Rouleau JL; Warnica JW; Burgess JH
    Am J Med; 1981 Jul; 71(1):147-52. PubMed ID: 7246572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of prazosin in severe congestive heart failure. An echocardiographic study.
    Drăgulescu SI; Comşulea L; Streian C
    Med Interne; 1984; 22(1):29-33. PubMed ID: 6710045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of oral prazosin therapy on exercise hemodynamics in patients with severe chronic heart failure.
    Chatterjee K; Rubin SA; Ports TA; Parmley WW
    Am J Med; 1981 Jul; 71(1):140-6. PubMed ID: 7246571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure.
    Hayashi H; Sassa H; Oba M; Fukaya T; Okubo M; Niwa T; Matsui E
    Jpn Heart J; 1980 Nov; 21(6):827-36. PubMed ID: 7007686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)].
    Mauri F; Gronda E; Bossi M; Rovelli F
    G Ital Cardiol; 1980; 10(4):414-23. PubMed ID: 7439582
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vasodilator treatment of chronic heart failure: a chronic double-blind trial with prazosin and erythrityl tetranitrate].
    Tomov I; Kaloianova A; Terzieva L; Elenkova A; Nikolov G
    Vutr Boles; 1981; 20(6):72-8. PubMed ID: 7039130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.
    Elkayam U; Mathur M; Frishman W; LeJemtel T; Strom J; Sonnenblick EH
    Clin Pharmacol Ther; 1981 Jul; 30(1):23-30. PubMed ID: 7237894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
    Miller RR; Awan NA; Maxwell KS; Mason DT
    N Engl J Med; 1977 Aug; 297(6):303-7. PubMed ID: 889599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ambulatory prazosin treatment of chronic congestive heart failure: development of late tolerance reversible by higher dosage and interrupted substitution therapy.
    Awan NA; Lee G; DeMaria AN; Mason DT
    Am Heart J; 1981 May; 101(5):541-7. PubMed ID: 7223594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemodynamic effect of prazosin in congestive cardiac insufficiency of acute degree].
    López-Sendón J; Coma Canella I; Lombera F; Martin Jadraque L
    Rev Esp Cardiol; 1979; 32(3):253-9. PubMed ID: 493628
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of oral prazosin hydrochloride in congestive failure following acute myocardial infarction.
    Lopez-Sendon J; Coma-Canella I; Lombera F; Jadraque LM
    Am Heart J; 1979 Oct; 98(4):495-504. PubMed ID: 484435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The hemodynamic effects of oral prazosine and intravenous nicergoline in heart failure (author's transl)].
    Pornin M; Roland E; Lardoux H; Sellier P; Ourbak P; Maurice P
    Ann Cardiol Angeiol (Paris); 1980; 29(5):379-84. PubMed ID: 7425504
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-invasive radiocardiographic assessment of the effects of prazosin in congestive heart failure.
    Nakajima H; Yui Y; Kawashita K; Yoshida A; Kawai C
    Jpn Circ J; 1982 May; 46(5):468-72. PubMed ID: 7077811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of vasodilators in congestive cardiac insufficiency: studies with prazosin].
    Conti CR; Miles D; Mehta J
    Cardiology; 1980; 66 Suppl 2():186-92. PubMed ID: 7285029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.